<i>Clostridium butyricum</i>, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation-Reference-Cited by-全球学者库

Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation

Published:2022 Issue:13 Volume:13 Page:7046-7061
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Wu Jingyi¹^ORCID,Zhou Bingqian¹,Pang Xiaoqi¹,Song Xueli¹,Gu Yu¹,Xie Runxiang¹,Liu Tianyu¹,Xu Xin¹,Wang Bangmao¹,Cao Hailong¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China

Abstract

Clostridium butyricum could ameliorate DSS-induced colitis through the transactivation of EGFR signaling induced by EGFR ligands (HB-EGF and AREG) in intestinal epithelial cells.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D2FO00478J

Reference61 articles.

1. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management

2. The four epidemiological stages in the global evolution of inflammatory bowel disease

3. Comorbidities in inflammatory bowel disease: a call for action